US20040181160A1 - Electrophysiological cardiac mapping system based on a non-contact non-expandable miniature multi-electrode catheter and method therefor - Google Patents

Electrophysiological cardiac mapping system based on a non-contact non-expandable miniature multi-electrode catheter and method therefor Download PDF

Info

Publication number
US20040181160A1
US20040181160A1 US10807941 US80794104A US2004181160A1 US 20040181160 A1 US20040181160 A1 US 20040181160A1 US 10807941 US10807941 US 10807941 US 80794104 A US80794104 A US 80794104A US 2004181160 A1 US2004181160 A1 US 2004181160A1
Authority
US
Grant status
Application
Patent type
Prior art keywords
probe
endocardial
heart
potentials
end portion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10807941
Inventor
Yoram Rudy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Case Western Reserve University
Original Assignee
Case Western Reserve University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B17/22004Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves
    • A61B17/22012Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves in direct contact with, or very close to, the obstruction or concrement
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/04Detecting, measuring or recording bioelectric signals of the body or parts thereof
    • A61B5/0402Electrocardiography, i.e. ECG
    • A61B5/0408Electrodes specially adapted therefor
    • A61B5/042Electrodes specially adapted therefor for introducing into the body
    • A61B5/0422Multiple electrode holders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6847Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
    • A61B5/6852Catheters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6847Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
    • A61B5/6852Catheters
    • A61B5/6855Catheters with a distal curved tip
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6847Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
    • A61B5/6852Catheters
    • A61B5/6856Catheters with a distal loop
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6847Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
    • A61B5/6852Catheters
    • A61B5/6857Catheters with a distal pigtail shape
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B34/00Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
    • A61B34/20Surgical navigation systems; Devices for tracking or guiding surgical instruments, e.g. for frameless stereotaxis
    • A61B2034/2046Tracking techniques
    • A61B2034/2051Electromagnetic tracking systems
    • A61B2034/2053Tracking an applied voltage gradient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/04Detecting, measuring or recording bioelectric signals of the body or parts thereof
    • A61B5/04011Vector-cardiography
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
    • A61B6/12Devices for detecting or locating foreign bodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
    • A61B6/50Clinical applications
    • A61B6/503Clinical applications involving diagnosis of heart
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/08Detecting organic movements or changes, e.g. tumours, cysts, swellings
    • A61B8/0833Detecting organic movements or changes, e.g. tumours, cysts, swellings involving detecting or locating foreign bodies or organic structures
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/08Detecting organic movements or changes, e.g. tumours, cysts, swellings
    • A61B8/0883Detecting organic movements or changes, e.g. tumours, cysts, swellings for diagnosis of the heart

Abstract

A system and method for determining electrical potentials on an endocardial surface of a heart is provided. The system includes a spiral-shaped non-contact, multi-electrode catheter probe, a plurality of electrodes disposed on an end portion thereof, means for determining endocardial potentials based on electrical potentials measured by the catheter probe, a matrix of coefficients that is generated based on a geometric relationship between the probe surface, and the endocardial surface.

Description

    ACKNOWLEDGMENTS
  • [0001] This research is supported by the National Institutes of Health, Grant No. 2 RO1 HL-33343 (Sponsor: NIH-NHLRI).
  • BACKGROUND OF THE INVENTION
  • This invention relates to an apparatus and method for electrophysiological cardiac mapping. More particularly, the invention is directed to a system based on a nonexpandable, noncontact, miniature, multielectrode catheter which is used to measure electrical potentials within a heart cavity. These measured potentials are then used, along with data on the geometric relationship between the catheter and the endocardial surface, to reconstruct maps representing endocardial electrical activity. In this regard, electrograms and isochrones are reconstructed. [0002]
  • While the invention is particularly directed to the art of electrophysiological cardiac mapping, and will be thus described with specific reference thereto, it will be appreciated that the invention may have usefulness in other fields and applications. [0003]
  • By way of background, endocardial potential mapping is a tool for studying cardiac excitation and repolarization processes. Mapping endocardial potential distribution and its evolution in time is useful for analyzing activation and repolarization patterns and for locating arrhythmogenic sites and regions of abnormal electrical activity in the heart. Accurate localization of arrhythmogenic sites is important to the success of non-pharmacological interventions, such as catheter ablation. [0004]
  • Unfortunately, current techniques of mapping potentials directly from the endocardium present certain difficulties. For example, the well-known “roving” probe approach is 1) limited in the number of recording sites, 2) too time consuming and 3) only operative to collect data over a plurality of heart beats, instead of a single beat. Therefore, this approach is not useful on a beat-by-beat basis to study dynamic changes in the activation process. [0005]
  • In addition, multiple electrode balloons or sponges have also been used to map electrical activity of the heart by way of measuring potentials within a heart cavity. Although capable of mapping the entire endocardium, these devices occlude the heart cavity and require open heart surgery, heart-lung bypass and other complicated and high risk procedures. [0006]
  • Another device having a multiple-spoke, basket-shaped recording catheter allows simultaneous acquisition of potential data from multiple electrodes without occluding the cavity. However, the basket is nonetheless limited in the number of electrodes so that spatial resolution is relatively low. Moreover, it is difficult to insure that all electrodes make contact with the endocardium. Also, the basket can be entangled in intracavitary structures such as the chordae tendineae. The fact that the basket must be collapsed prior to catheter withdrawal from the ventricle adds complexity and risk to this procedure. [0007]
  • Still another known device for detecting endocardial potentials uses an electrode array catheter that can be expanded within the heart chamber but does not occlude the heart chamber. However, this system still involves undesirable expansion of a device in the heart chamber. The expanded element may interfere with intracavity structures and adds complexity to the system because it must be collapsed before removal. Moreover, it is difficult to determine the location of the electrodes within the chamber. Also, the array may not expand as desired, leading to inaccuracies in mapping. [0008]
  • Taccardi et al. developed an alternative indirect mapping approach that makes use of a large (too large for clinical applications) intracavitary multielectrode catheter-probe (olive shaped or cylindrical), that can be introduced into the blood filled cavity without occluding it. The probe permits simultaneous recording of intracavitary potentials from multiple directions but, unlike the balloon, is not in direct contact with the endocardium and does not record actual endocardial potentials. The intracavitary probe potentials exhibit smoothed-out distributions and do not reflect details of the excitation (or repolarization) process that can be detected and located by direct endocardial recordings. It is highly desirable, therefore, to develop an approach for reconstructing endocardial potentials, electrograms and isochrones from data recorded with a small, non-expanding intracavitary catheter-probe that can be introduced percutaneously, does not occlude the ventricle, and/or does not require opening large structures (e.g. basket or balloon) inside the cavity. [0009]
  • Accordingly, it would be desirable to have available a multielectrode catheter probe that can be introduced percutaneously, without expanding inside the ventricular cavity, and provide accurate reconstructed endocardial potentials, electrograms and isochrones. [0010]
  • The present invention contemplates a new and improved system and method for electrophysiological cardiac mapping using a non-contact, non-expandable catheter which resolves the above referenced difficulties and others and attains the above referenced desired advantages and others. [0011]
  • SUMMARY OF THE INVENTION
  • A system for determining electrical potentials on an endocardial surface of the heart is provided. In one aspect of the invention, the system contains a noncontact, non-expandable, miniature catheter probe that is percutaneously positioned inside a heart cavity. A plurality of electrodes are disposed on an end portion of the probe whereby electrical potentials within the heart cavity are measured. Also included is a means for generating a matrix of coefficients which is then used along with the electrical catheter potentials to determine endocardial potentials. [0012]
  • In a further aspect of the invention, the probe assumes a curved shape inside the cavity. [0013]
  • In a further aspect of the invention, the system includes means for generating electrograms and isochrones based on the determined endocardial potentials. [0014]
  • In a further aspect of the invention, the curved shape of the terminal end of the electrode catheter resembles a “J”, “U”, “O”, helix, pigtail, or any general curved shape. [0015]
  • In a further aspect of the invention, the system includes a means for conforming the terminal end portion of the probe to the first elongated shape and a means for conforming the terminal end of the end portion of the probe into the second curved shape. [0016]
  • In a further aspect of the invention, a method for implementing the system is provided. [0017]
  • Further scope of the applicability of the present invention will become apparent from the detailed description provided below. It should be understood, however, that the detailed description and specific examples, while indicating preferred embodiments of the invention, are given by way of illustration only, since various changes and modifications within the spirit and scope of the invention will become apparent to those skilled in the art.[0018]
  • DESCRIPTION OF THE DRAWINGS
  • The present invention exists in the construction, arrangement, and combination of various parts of the device and steps of the methods, whereby the objects contemplated are attained as hereinafter more fully set forth, specifically pointed out in the claims, and illustrated in the accompanying drawings in which: [0019]
  • FIG. 1([0020] a) is a representative illustration of the system according to the present invention;
  • FIG. 1([0021] b) is an illustration of the catheter according to the present invention positioned within a heart cavity;
  • FIG. 2 is a side view of an end portion of a catheter probe according to the present invention having a first shape; [0022]
  • FIG. 3 is a side view of the end portion of the catheter probe according to the present invention having a second shape; [0023]
  • FIGS. [0024] 4(a)-(e) are side views of the end portion of various catheter probes according to the present invention having another second shape;
  • FIG. 5([0025] a) is a functional block diagram of the processor according to the present invention;
  • FIG. 5([0026] b) is a flow diagram illustrating a software tool implemented according to the present invention;
  • FIG. 6 is a flow chart showing the method according to the present invention; [0027]
  • FIG. 7 is a schematic representing the geometry of a human ventricular cavity containing a probe; [0028]
  • FIG. 8 shows selected sites on the endocardial surface for electrogram display in utilizing the present invention; [0029]
  • FIG. 9 includes electrograms showing results obtained using the present invention; [0030]
  • FIG. 10 includes electrograms showing results obtained using the present invention; [0031]
  • FIG. 11 includes electrograms showing results obtained using the present invention; [0032]
  • FIG. 12 includes isochrone maps showing results obtained using the present invention; [0033]
  • FIG. 13 includes isochrone maps showing results obtained using the present invention; [0034]
  • FIG. 14 is an illustration explaining geometric and rotational errors; [0035]
  • FIG. 15 includes electrograms showing results obtained using the present invention; [0036]
  • FIG. 16 includes isochrone maps showing the effects of probe rotation of 5/on the present invention; [0037]
  • FIG. 17 includes isochrone maps showing the effects of probe rotation of 10/on the present invention; [0038]
  • FIG. 18 includes isochrone maps showing the effects of probe rotation of 5/and [0039] 10/on the present invention;
  • FIG. 19 includes electrograms showing the effects of probe shift on the present invention; [0040]
  • FIG. 20 includes isochrone maps showing the effects of probe shift on the present invention; [0041]
  • FIG. 21 includes isochrone maps showing the effects of probe shift on the present invention; [0042]
  • FIG. 22 includes electrograms showing the +effects of twisting on the present invention; [0043]
  • FIG. 23 includes isochrone maps showing the effects of twisting on the present invention; [0044]
  • FIG. 24 includes electrograms showing the effects of catheter probe shape on the present invention; [0045]
  • FIG. 25 includes isochrone maps showing the effects of catheter shape on the present invention; [0046]
  • FIG. 26 includes isochrone maps showing the effects of catheter shape on the present invention; [0047]
  • FIG. 27 includes isochrone maps showing the effects of catheter shape on the present invention; [0048]
  • FIG. 28 includes isochrone maps showing the effects of catheter shape on the present invention; [0049]
  • FIG. 29 includes measured and computed potential maps; and, [0050]
  • FIG. 30 includes measured and computed potential maps.[0051]
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • A mathematical inverse methodology for reconstruction of endocardial potentials, electrograms and isochrones from non-contact, intracavitary probe measurements has been developed and validated. A study in an isolated canine left ventricle (LV) demonstrated that the inversely computed endocardial potential maps reconstruct with good accuracy and resolve the major features of the measured endocardial potential maps, including maxima, minima and regions of negative and positive potentials. A more recent systematic evaluation demonstrated that computed temporal electrograms and isochrones also closely approximate their directly measured counterparts. The isochronal maps correctly captured the regions of early and late activation for a single pacing site and for two simultaneous pacing sites separated by 17 mm. Moreover, the entire activation sequence was closely approximated, including regions of nonuniform conduction (e.g. isochrone crowding indicating slow conduction). The size of the probe, though, was too large for clinical application. [0052]
  • The reconstruction methodology can be adapted to the clinical environment with two additional developments: (1) reduction in size of the intracavity multielectrode probe; and (2) noninvasive determination of the geometric relationship between the probe and the endocardium. A 9-French (3-mm) multielectrode catheter that can be introduced percutaneously has been developed. The present invention demonstrates that endocardial potentials can be reconstructed from a 3-mm cylindrical probe with accuracy. [0053]
  • In the experiments (the results of which are outlined herein with reference to FIGS. 8-30), the geometry of the endocardium was determined invasively after completion of the potential measurements. The ability to measure the geometry directly improved accuracy. However, the fact that the geometry was not obtained at the time of potential measurements introduced an error, since myocardial changes upon termination of perfusion changed somewhat the positions of the intramural needles. Moreover, all computations assumed a single cavity geometry (end-diastolic volume) throughout the experiment, whereas the degree of blood filling varied between pacing protocols and between time frames during a given protocol. The probe positions/orientation within the cavity was estimated using an automated optimization procedure and was subject to error as well. [0054]
  • Nonetheless, the experiments confirm that, in spite of geometry errors, electrograms and isochrones can be reconstructed over the entire endocardium with good accuracy. This property is useful in terms of clinical application of the approach. [0055]
  • As will be described below, existing noninvasive imaging techniques, such as ultrasound, can provide the endocardial geometry and probe position simultaneously and at the time of potential measurements. This constitutes an improvement over the method used in the experiments. The geometric robustness of the reconstruction procedure implies that it could be combined with a noninvasive imaging modality (high accuracy can be achieved with transesophageal echocardiography for example) to reconstruct endocardial potentials, electrograms, and isochrones on a beat-by-beat basis in the clinical catheterization laboratory. [0056]
  • Referring now to the drawings wherein the showings are for purposes of illustrating the preferred embodiments of the invention only and not for purposes of limiting same, FIG. 1([0057] a) provides a view of the overall preferred embodiment. As shown, the system 10 includes a catheter probe 12—which is positioned in a cavity of the heart H by well known methods—a processor (or computer) 14, an imaging (or geometry determining) device 16, an output device 18 (which may take the form of a display (as shown), or a printer or other suitable output device), and a mechanism 20 for steering and manipulating an end portion of catheter probe 12. FIG. 1(b) shows the catheter 12 (shown in an exemplary curved shape) positioned in the heart H.
  • The end portion [0058] 30 of catheter probe 12, as shown in FIG. 2, is generally cylindrical in cross section and has disposed thereon a plurality of electrodes, exemplary shown at 32. It should be noted that herein, like numerals in the drawings indicate like elements. Preferably, the catheter probe is a 9-French (9 F), 3.0 mm catheter; however, any usable style and size will suffice. For clinical applications, of course, the catheter is preferably of a size to facilitate percutaneous introduction into the cavity. The number of electrodes may vary depending on the needs of the particular application. Of course, varying the number of electrodes consequently impacts the results obtained using the invention, as will be more particularly described hereinafter.
  • As illustrated in FIG. 3, the end portion of the catheter probe [0059] 12 may be conformed to a curved shape of FIG. 3 once positioned in the heart cavity. As shown, the exemplary shape is that of a “J”. It should be emphasized that the label “J” (and other similar labels) refers to the end portion of the catheter that has electrodes disposed thereon, not the entire catheter. The end portion is conformed to this shape by known methods and the mechanism 20 represented generally in FIG. 1, as those skilled in the art will appreciate.
  • Of course, the precise shape of the end portion [0060] 30 of the catheter probe 12 may be varied to suit a particular application of the catheter probe. For example, the end may be conformed to a “U,” “O”, pigtail, helix or any known curve. As is shown in FIG. 4(a), the exemplary “U” shaped catheter end portion shape is shown whereby the end portion is further manipulated from the J-shape to resemble a “U”. The angle of curvature is preferably the same as that of the J-shaped configuration but it is recognized that the angle of curvature may be varied without affecting the scope of the invention. FIGS. 4(b)-(e) show curved catheters having end portions conformed to an “O”, a pigtail, a helix, and a general representative curve, respectively. It should be appreciated that varying the shape of the end portion of the catheter probe impacts the results obtained using the invention, as will be more particularly described hereinafter but, importantly, the invention and resultant test data indicate that a noncontact, nonexpandable, miniature multielectrode catheter probe of any shape or configuration (including straight) is useful for cardiac mapping.
  • Referring now to FIG. 5([0061] a), functional blocks of the processor 14 are described. Those skilled in the art will appreciate that the processor 14 actually includes suitable software and hardware (including, for example, memories) that accomplish the functions described. In one embodiment, the software tool implemented takes the general form of that described in connection with FIG. 5(b), although neither the processor nor the tool is so limited. For example, it should be recognized that the software tool of FIG. 5(b) has features involving testing and validation which are not specifically described in connection with FIG. 5(a) but would be apparent to those of skill in the art.
  • Specifically, as shown in FIG. 5([0062] a), data on geometry of the endocardium and probe are input to the processor 14 from the imaging device 16. Such data may be generated using existing imaging modalities such as x-ray, ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), . . . etc. Preferably, the invention is implemented using bi-plane x-ray techniques enhanced with fluoroscopy. These techniques result in determination of a geometric envelope that approximates the heart chamber.
  • As is shown in FIG. 5([0063] a), at least one of these known imaging routines is available to provide data to determine a geometric relationship of the endocardial surface (or envelope) and probe surface (block 141) based on the input of the imaging device 16. A matrix of coefficients A, described in more detail below, is also generated (block 142) in the processor. In addition, data, i.e. electrical potentials measured in the heart cavity, is input to the processor from the probe 12. These data are stored in the processor (block 143). Endocardial potentials may then be determined by the processor based on the stored electrical potentials and the matrix of coefficients (block 144). Electrograms and isochrone maps are also generated for display and evaluation (block 145). The results, of course, may be output.
  • As noted above, the software tool may take the general form of the flow diagram illustrated in FIG. 5([0064] b), but those skilled in the art will appreciate that such a program, which (as will be described) also accommodates testing and validation processes, may well be modified and/or evolve into a modified tool (to resemble, for example, only the features described in connection with FIG. 5(a)) as the present invention is modified as a result of additional development or needs of users. Those skilled in the art will also appreciate that the description of this software tool necessarily overlaps with the description in connection with FIG. 5(a) because the processor of FIG. 5(a) implements such software tools in the described embodiment.
  • As shown, information is input to the system (step [0065] 500). Specifically, parameters are input to the system by the user (step 502). Geometry data and potential data are also input (steps 504, 506). It should be recognized that in a clinical setting, the geometry data is generated by imaging device 16 and potential data is generated by catheter probe 12; however, if the software tool is T implemented for testing and validation purposes, the geometry data may be known parameters, such as those associated with geometric spheres and torso tanks (used in testing), that are simply input to the system. The overall control program is implemented (step 508) and it is determined whether to use the software tool for testing and validation (using sphere or torso tank data (steps 510, 512)) or clinical application (using clinical data (step 514)). Appropriate processing is then conducted on the data (steps 516, 518 or 520), as will be apparent to those skilled in the art, to prepare the data for necessary mathematical manipulation.
  • Next, a boundary element method (further described below) is applied (step [0066] 522). At that time, forward (step 524) or inverse (step 526) computations, as necessary, are performed. Of course, for clinical applications, only inverse computations (as described below) are used. Once the data is computed, processing of the data for output is accomplished (step 528).
  • Referring now to FIG. 6, the overall method [0067] 600 by which endocardial potentials (and electrograms and isochrones) may be determined according to the present invention is described. Initially, a probe 12 is percutaneously positioned in the cavity of a heart by known methods (step 602). If desired, the end portion of the probe is then conformed, utilizing mechanism 20, to a curved shape such as those shown in FIGS. 3 and 4(a)-(e) (step 604). It is recognized that conforming the end portion may not be necessary if the results obtained by using the straight catheter (of FIG. 2, for example) are acceptable. Potentials are then measured in the cavity (step 606) and stored (step 608).
  • A geometric relationship between the probe surface and the endocardial surface (or envelope) is also determined (step [0068] 610). The geometry is, of course, determined using the imaging device 16. Based on this data on the geometric relationship, a matrix of coefficients A is generated. (step 612).
  • Next, endocardial potentials are determined based on the stored potentials and the matrix of coefficients (step [0069] 614). Electrograms and isochrones are then generated by the processor (steps 616 and 618) and displayed (step 620). The procedure is then ended (step 622).
  • The mathematical computations accomplished by the processor [0070] 14 involved in implementing the present invention described above relate to and should be analyzed by considering “forward” computations, i.e. calculating catheter probe potentials from known endocardial surface potentials, and “inverse” computations, i.e. calculating endocardial surface potentials based on measured probe potentials. Of course, the inverse computation is the computation that is used for implementation of the present invention (e.g. step 614 in FIG. 6), but understanding the forward computation is also useful.
  • While various forward and inverse computations are known, the computations involved in connection with the present invention are as follows. More particularly, computation of probe potentials based on measured endocardial potentials (the “Forward Problem”) requires solving Laplace's equation in the cavity volume (Ω) bounded by the probe surface (S[0071] P) and the endocardial surface (Se), as illustrated in FIG. 7.
  • Below is a description of the mathematical formulation. Further details can be found in previous publications such as Khoury D S, B. Taccardi, Lux R L, Ershler P R, Rudy Y, “Reconstruction of endocardial potentials and activation sequences from intracavitary probe measurements” [0072] Circulation, 91:845-863 (1995); Rudy Y, Messinger-Rapport B J, “The inverse problem in electrocardiography solutions in terms of epicardial potentials,” CRC Crit Rev Biomed Eng., 16:215-268 (1988); Rudy Y, Oster H S, “The electrocardiographic inverse problem,” CRC Crit Rev Biomed Eng., 20:25-46 (1992), Messinger Rapport B J, Rudy Y, “Computational issues of importance to the inverse recovery of epicardial potentials in a realistic heart-torso geometry,” Math Biosci, 97:85-120 (1989) (published erratum in Math Biosci, 99(1):141 (1990 April)).; Oster H S, Rudy Y, “The use of temporal information in the regularization of the inverse problem of a electrocardiography,” IEEE Trans Biomed Ena., 39:65-75 (1992); and Messinger Rapport B J, Rudy Y, “Regularization of the inverse problem in electrocardiography. A model study,” Math Biosci, 89:79-118 (1988), all of which are hereby incorporated herein by this reference.
  • The behavior of potential, V, within Ω is governed by Laplace's equation: [0073]
  • 2 V=0 in Ω  (1)
  • subject to the boundary conditions: [0074] V = V e on a subset of S p ( 2 )
    Figure US20040181160A1-20040916-M00001
    V/∂n =0 on S p  (3)
  • where V[0075] p is the potential on the probe surface; ∂V/∂n=0 implies that current cannot enter the nonconducting probe. A well-known Boundary Element Method (BEM) (See, for example, Brebbia C A, Dominguez J, Boundary elements: An Introductory Course, McGraw-Hill Book Co., New York (1989) or Brebbia et al., Boundary Element Techniques. Theory and Applications in Engineering, Springer Verlag, Berlin (1984)) is used to numerically solve for the potentials in a realistic geometry cavity-probe system. This results in the following equation that relates the probe potentials to the endocardial potentials:
  • V P =A ·V e  (4)
  • where VP is a vector of probe potentials of order N[0076] p (probe surface nodes), Ve is a vector of endocardial potentials of order Ne (endocardial surface nodes), and A is an Np×Ne matrix of influence coefficients determined by the geometric relationship between the probe surface and the endocardial surface. The intracavitary probe potentials can be calculated from the endocardial potentials using equation (4). Since the forward computation is a stable and accurate process, the computed probe potentials provide an accurate estimate of cavity potentials measured by an actual probe of the same design and in the same intracavitary position. This calculation is useful to verify data that are obtained using the inverse computation.
  • The matrix A in equation (4) is determined by the geometrical relationship between the endocardial surface and the probe surface. Specifically, it requires specification of node positions (corresponding to electrode positions) on the probe and node positions on the endocardium. Geometry data, as noted above, is obtained from the imaging device [0077] 16 which, again, may involve any of the known imaging modalities. Errors in determining the node positions on these two surfaces, especially probe electrodes, may be amplified due to the nature of the inverse procedure and might consequently introduce errors in the reconstructed endocardial potentials. Accordingly, accurate T determination of geometry is important for implementation.
  • In order to compute endocardial electrograms and isochrones, endocardial potential maps are first computed in a quasi-static fashion for every millisecond throughout the endocardial activation process. Computing endocardial potentials is the first step in computing temporal electrograms and isochrones. To compute endocardial potentials from probe potentials, the relationship between V[0078] e and VP established in equation (4) must be inverted. However, because of the ill-posed nature of the problem (as described in Rudy Y, Messinger-Rapport B J, “The inverse problem in electrocardiography: solutions in terms of epicardial potentials,” CRC Crit Rev Biomed Eng., 16:215-268 (1988)), one cannot simply invert matrix A to obtain the endocardial potentials (Ve) from probe potentials (VP). A Tikhonov regularization technique is used to stabilize the procedure (See, for example, Tikhonov A N, Arsenin V Y, “Solution of Ill-Posed Problems,” 27-94, V H Winston & Sons, Washington, D.C. (1977), or Tikhonov et al., “Solutions of ill-posed problems,” (trans. from Russian) Wiley, NY (1977), which are incorporated herein by reference), and the solution for endocardial potentials is obtained by minimizing the objective function: min v e [ V p - A · V e 2 + t V e 2 ( 5 )
    Figure US20040181160A1-20040916-M00002
  • or, more generally, minimizing [0079]
  • ||V p −A·V e||2 +tF[V e]
  • where t is a regularization parameter, whose optimal value was determined using the CRESO (composite residual and smoothing operator) method (See, Colli-Franzone P, Guerri L, Taccardi B. Viganotti C, “Finite element approximation of regularized solutions of the inverse potential problem of electrocardiography and t applications to experimental data” Calcolo 1985, 22:91-186, and Colli-Franzone et al., “Mathematical procedure for solving the inverse problem of electrocardiography,” [0080] Math Biosci, 77:353-96 (1985), which are incorporated herein by reference).
  • The approach to verifying the accuracy of the data obtained is based on a combination of experimentally measured endocardial potentials and simulated catheter probes in an isolated LV preparation. The simulated catheter data is used to reconstruct endocardial electrograms and isochrones, which are then evaluated by direct comparison with their measured counterparts. [0081]
  • In contrast to potentials, electrograms and isochrones provide complete spatio-temporal information for the entire activation cycle. Endocardial electrograms provide temporal information on activation in localized areas and are widely used in clinical practice. Isochrones provide extensive spatio-temporal information about the entire activation sequence that can be seen in one glance. Isochronal maps also can identify spatial nonuniformities of propagation such as regions of slow conduction or areas of conduction block that are important mechanistic properties of arrhythmogenic activity. Therefore, it is useful to evaluate the accuracy with which electrograms and isochrones can be reconstructed from the noncontact catheter. Single-site pacing protocols as well as simultaneous dual-site pacing were employed. Because electrograms and isochronal maps contain temporal information from the entire cardiac cycle, their accurate reconstruction places more demanding design criteria on the catheter probe. The results below demonstrate that, as in the case of potential reconstruction, endocardial electrograms and isochrones can be accurately reconstructed from a noncontact, nonexpandable, miniature multielectrode 9 F catheter that may, if desired, assume a curved geometry inside the cavity, without the need for expansion. The catheter need not be curved to work effectively. Curvature simply enhances the results, as will be demonstrated. The reconstruction is robust in the presence of errors, indicating feasibility of the approach in the clinical environment of the electrophysiology (EP) catheterization laboratory. [0082]
  • To obtain an accurate estimate of probe potentials, the forward computation of probe potentials from the measured endocardial potentials was performed with a very large number of electrodes (nodes) on the probe surface. In the simulation, probes with 722 electrodes (30 circumferential rows×24 electrodes/row+two end electrodes) were used. This is several times greater than the actual number of electrodes on the probe used in the experiments. As confirmed by spherical model simulations, such a large number of electrodes (nodes) results in very accurate probe potentials. To study the effect of limited electrode density on the reconstruction, different subsets of electrodes (nodes) were selected on the surface of the simulated probe. The uniform spatial distribution of electrodes over the probe surface was preserved. The selected subset of probe potentials was then used in the inverse reconstruction of endocardial potentials. This process was performed for probes of different sizes and shapes. [0083]
  • The reconstruction of endocardial potential maps is performed in a quasi-static approach throughout the cardiac cycle, i.e., at a given time instant, the endocardial map is computed from the probe potentials recorded at the same time. Once all endocardial potential maps are reconstructed, the data are reorganized according to electrode (node) and temporal electrograms depicting potential vs. time can be reconstructed for any position on the endocardial surface. In this study, endocardial potentials and electrograms were computed for 50 positions, where the tip electrodes of endocardial recording needles were located, allowing a direct comparison of the computed electrograms with the actual measured electrograms. [0084]
  • Endocardial isochrones, depicting the activation sequence of the endocardial surface, were constructed from the computed endocardial electrograms. The time derivatives, dV/dt, of the inversely reconstructed endocardial electrograms were computed, and the time instant associated with the maximum negative dV/dt (“intrinsic deflection”) at a particular site was taken as the activation time of that site. [0085]
  • Over the entire endocardial surface, 50 electrograms were computed. Electrograms at 5 selected sites are shown in the results. FIG. 8 shows the positions of these selected (numbered) sites. For both single and dual pacing cases, site [0086] 1 was chosen to be the earliest (one of the earliest, in the dual pacing case) measured endocardial activation site, while sites 2 to 4 are activated progressively later in time. Site 5 corresponds to a site that is remote from the center of the cavity and therefore far away from the catheter probe. The asterisks correspond to pacing sites.
  • In the following description of experimental results, three representative simulated catheter probes are compared in terms of accuracy of T reconstructed endocardial electrograms and isochrones. The probes are: a cylindrical 7.6 mm diameter probe (generally too large for percutaneous application), a cylindrical 3.0 mm diameter probe (equivalent to a 9 F catheter that can be introduced percutaneously), and a 3.0 mm diameter probe bent in the cavity into a J-shape (close to the natural shape assumed by a catheter in the cavity). Results with simulated probes larger than the 7.6 mm cylindrical probe are very similar to those of the 7.6 mm probe. Initial results for a simulated U-shaped catheter probe are also shown to demonstrate the effects of different curved catheter shapes on the reconstructions. [0087]
  • It should also be recognized that potential maps may also be generated using the system and method of the present invention. For example, FIG. 29 shows measured and computed potentials for a single pacing site using 122 and 62 electrodes, respectively, for the noted catheters. FIG. 30 shows similar data for dual pacing sites. [0088]
  • FIG. 9 shows the reconstruction of endocardial electrograms from different probes containing 122 electrodes. The activation sequence is initiated by pacing from a single site. Measured endocardial electrograms at 5 selected sites are shown at the top, reconstructed electrograms at corresponding sites are shown at the bottom. The correlation coefficients (CC) between the measured and computed electrograms are printed next to each computed electrogram. Over the entire endocardium, computed electrograms at 50 endocardial sites resemble the measured electrograms very well. CC values at all sites are near 1.0. [0089]
  • FIG. 10 shows reconstruction of endocardial electrograms from the probes using a subset of 62 electrodes. The cylindrical 7.6 mm probe performs almost as accurately as with 122 electrodes, except for the distant site (site [0090] 5). The cylindrical 3.0 mm and curved probes reconstruct 96% of the electrograms with CC greater than 0.90. There are discontinuities (“jagged” appearance or spikes) in some of the computed electrograms, which do not exist in the measured ones. Although the discontinuities cause deterioration of the appearance of the electrograms, the general shapes of the electrograms are preserved. Electrogram at the distant site (site 5) reconstructed from the curved probe resembles the measured electrogram in terms of shape and amplitude. The computed electrograms at a few nodes contain large spikes in certain time frames, the computed electrograms resemble the measured ones very well except during the spikes. The spike can be removed by data interpolation.
  • FIG. 11 shows endocardial electrograms reconstructed from the probes with 62 electrodes for a dual-site pacing protocol. The overall performance of the J-probe is most acceptable, with high CC. The distant node electrogram (site [0091] 5) is also reconstructed with very high accuracy.
  • Endocardial isochrones were constructed from both measured and inversely reconstructed endocardial electrograms. FIG. 12 shows the isochrones computed from the reconstructed electrograms of FIG. 9 and FIG. 10. The measured isochrone map is shown in the top panel and the computed isochrone maps in the bottom panels. The position of the earliest activation time in the measured isochrone map is located at the pacing site, indicated by an asterisk (*). The map shows that activation starts at the postero-lateral region and progresses to the anteroseptal region towards the base of the LV. The regions of both earliest activation and latest activation in the measured isochrone map are accurately reconstructed in the computed isochrone map by the 7.6 mm cylindrical and curved catheter with either 122 or 62 electrodes. In contrast, the reconstructed isochrones using the 3.0 mm cylindrical probe with 62 electrodes (second row) exhibit distortion of the earliest activation region, and the latest region (red) divides into two regions. The intermediate isochrones between the earliest and latest activation times in the computed isochrone map closely resemble the measured isochrones for all three probes. The reconstructed earliest activation time (17 ms) is accurate. The latest time of activation reconstructed by the curved catheter with 62 electrodes is 60 ms as compared to the measured value of 63 ms. [0092]
  • FIG. 13 shows the activation sequences (isochrones) initiated by the dual-pacing protocol of FIG. 11. The measured isochrone maps (FIG. 13 top panel) depict two distinct earliest activation regions at the vicinity of the two pacing sites. The earliest activation times determined from the measured electrograms are 18 ms for the two posterior pacing sites. The latest activation region is at the anteroseptal region close to the base of the LV, with activation time of 55 ms. In the isochrone maps computed from the curved catheter with 122 or 62 electrodes (bottom row), the two distinct earliest activation regions are correctly reconstructed. The earliest activation times in the computed isochrone maps are exactly 18 ms. The region of latest activation in the computed isochrone map is located at the anteroseptal region near the base of the LV, in good agreement with its actual location in the measured isochrone map. In contrast, only one of the T two early activation sites is present in the reconstructed isochrones obtained from the 7.6 mm and 3.0 mm cylindrical probes. [0093]
  • Geometrical errors can occur in determining the probe position inside the ventricular cavity. The two most probable errors are shifts and rotations of the probe as a rigid object. For the curved probe, twisting, i.e. rotation about the probe's own axis is also possible. These geometrical errors are illustrated in FIG. 14. [0094]
  • The effects of a 5-degree rotation error on electrogram reconstruction are shown in FIG. 15. All probes used are with 62 electrodes. For the 7.6 mm cylindrical probe, 88% of all the electrograms are reconstructed with CC greater than 0.95. The 3.0 mm cylindrical probe reconstructs 92% of the electrograms with CC greater than 0.95. Of the J-probe reconstructed electrograms, 90% have CC greater than 0.95. It should be noticed that a uniform degree of angular rotation actually results in different position errors for electrodes on the different probes. The 3.0 mm cylindrical probe experiences the smallest distance change, while electrodes on the J-probe “arm” experience the largest position error. This explains why the accuracy of J-probe reconstructions is sensitive to this type of error. In contrast, the 3.0 mm cylindrical probe tolerates the rotational error better than other disturbances. [0095]
  • FIG. 16 shows the isochrones computed from the electrograms of FIG. 15, which demonstrates the effects of a 5-degree angular rotation. FIG. 17 shows the results for 10-degree rotation. Despite the fact that the rotated J-probe has experienced a distance change, it still recovers acceptable activation regions. In the left column of FIG. 17, the J-probe and the 3.0 mm cylindrical probe recover the earliest activation region while the 7.6 mm cylindrical probe does not. In the right column, the J-probe recovers the earliest and latest activation regions with the least pattern deformation compared to the other probes. FIG. 18 shows the effects of probe rotation on a dual-pacing protocol. The 7.6 mm cylindrical probe recovers only one of the two pacing sites; the 3.0 mm cylindrical probe also reconstructs only one (the same) pacing site with greater smoothing. The J-probe identifies the two simultaneous pacing sites with high correlation coefficients of 0.88 for 5 degree rotation and 0.92 for 10 degree rotation. [0096]
  • It has been determined that reconstruction quality under the disturbance of rotation is related to the probe position inside the cavity, more specifically, the position of the J-probe relative to the characteristic sites (pacing site, earliest or latest activation region) influences the reconstruction quality. One possible approach is to simply rotate the same catheter probe in the cavity and record the potentials during two beats, with different rotational positions. Another solution is to introduce a second catheter probe into the cavity with an angle between the two probes, to provide data from two orientations during a single beat. Also as will be shown later, increasing the arm length of the J-probe to form a U-probe helps improve the accuracy of the reconstruction. [0097]
  • The effects of a shift in probe position on electrogram reconstruction are shown in FIG. 19. Overall, 68% of the recovered electrograms have correlation coefficients higher than 0.90. The 3.0 mm J-probe gives accurately reconstructed electrograms of the early activation sites (column [0098] 1, 2, 3) and of the distant node (column 5). However, it fails to accurately recover the latest activation site (column 4), the electrogram is severely distorted.
  • This is also reflected in the isochronal map of FIG. 20 left column, which is computed from the electrograms of FIG. 19 (2 mm shift). The early activation region is recovered with high accuracy by the 7.6 mm probe and the J-probe. The 3.0 mm cylindrical probe reconstructs the earliest activations site, which has shifted in the lower right direction. The cylindrical probes perform better than the J-probe in the latest activation region. 3 mm shift has the same effects on isochrone reconstruction as shown in FIG. 20, right column. FIG. 21 shows the same simulation for a dual pacing protocol. For 2 mm shift error, the 7.6 mm cylindrical probe reconstructs the earliest region with some distortion. The 3.0 mm cylindrical probe-only recovers one of the two pacing sites. The J-probe reconstructs the two earliest activation sites, also with some deformation of patterns in this region. Even for 3 mm shift error, the two earliest activation regions can be distinguished by the J-probe. [0099]
  • It has been determined that the tolerance of the reconstruction to probe shift errors is also related to the position of the probe inside the cavity. If a certain region of the endocardial surface is close to some probe electrodes, the region tolerates better positional errors. The reconstruction quality under the effects of shifting errors can also be improved by using similar approaches as those suggested in the context of the rotation errors. [0100]
  • FIG. 22 shows the electrograms reconstructed from a J-probe with 5 degrees, 10 degrees and 15 degrees twist errors, and FIG. 23 shows the corresponding isochrones. Electrograms display significant morphological distortions in most of the nodes. For 5 and 10 degrees twist, even with major morphological changes in the electrograms, the isochrones still recover the earliest activation region and the latest activation region (although the latter is smoothed out). Under 15 degrees twist, the latest activation region is completely smoothed out. For the dual-pacing protocol, the J-probe with 5 degrees twist can still identify the two earliest activation sites accurately. Under higher twist error, the two pacing sites merge together and can not be separated. [0101]
  • The J-probe used in this simulation study is characterized by a relatively short arm, as shown in FIG. 3. It serves to represent a large variety of curved catheter probes with either different curvature or other shapes, such as “U”, or “O”, or any curved shape. In order to evaluate the effects of different catheter shapes on the reconstruction quality, simulations for a U-shaped catheter probe (FIG. 4) have also been conducted. FIG. 24 shows the electrograms reconstructed from the 3.0 mm probe, the J-probe and a 3.0 mm U-probe also with 62 electrodes. The U-probe has the same curvature as the J-probe. Note that the computed electrograms from the 3.0 mm cylindrical and J-probe are the same as shown in FIG. 10. From the cylindrical probe to the U-probe, the accuracy of the reconstruction progressively improves with the length of the “arm”. The U-probe reconstructs the electrograms with very high accuracy, without any discontinuities or spikes. FIG. 25 left column shows the isochrones computed from the electrograms of FIG. 24. The improvement in the latest activation region of the isochrones reconstructed by the U-probe is evident. The right column of FIG. 25 shows the reconstructed isochrones from the three catheter probes with only 42 electrodes. The 3.0 mm cylindrical and J-shaped probes fail to recover the earliest activation region, however, the U-probe still accurately reconstructs both the earliest and latest activation regions. Reconstructed isochrones for the dual pacing protocol from the catheter probes are shown in FIG. 26. Only the U-probe, with either 62 or 42 electrodes, recovers the two distinct earliest activation regions accurately. FIG. 27 shows the reconstructed isochrones from the catheters under 5-degree rotation error. The performance of the U-probe is comparable or relatively better than the J-probe. Similarly, FIG. 28 shows the reconstructed isochrones from the catheters under 2 mm shift error. In the single pacing case (left column), the U-probe is the only one that recovers both the earliest and latest activation regions. [0102]
  • The results from the present study indicate that a noncontact, nonexpandable, miniature multielectrode catheter is useful for cardiac mapping. Although curving the catheter is not necessary to obtain relatively accurate results, such curving results in improved results in many respects. As is apparent from the above data, although a large number of electrodes is desirable when we consider the quality of the inverse reconstruction, it may raise other issues in design and manufacturing of the probe and the data acquisition system. Thus, for a J-probe, 60 probe electrodes or more is desirable because it reconstructed the endocardial electrograms and isochrones with good accuracy. However, the U-probe was found to tolerate reduced electrode number down to 42 very well. [0103]
  • The above description merely provides a disclosure of particular embodiments of the invention and is not intended for the purpose for limiting the same thereto. As such, the invention is not limited to only the above described embodiments. Rather, it is recognized that one skilled in the art could conceive alternative embodiments that fall within the scope of the invention. [0104]

Claims (18)

    What is claimed is:
  1. 1. A probe for measuring electrical potentials in a heart cavity, the probe comprising:
    a terminal end portion including a plurality of electrodes, the terminal end portion conformed into a spiral shape and positioned for non-contact with the endocardial surface,
    where the probe is inserted percutaneously.
  2. 2. A probe according to claim 1 further comprising means for conforming the terminal end portion into a spiral shape.
  3. 3. A probe according to claim 1, where the terminal end portion comprises a generally cylindrical shape.
  4. 4. A probe according to claim 1, where the spiral shape includes at least one of: a pigtail shape and a helix.
  5. 5. A probe according to claim 1, where the probe provides electrical potentials for reconstructing endocardial potentials on the endocardial surface.
  6. 6. A probe according to claim 5, where the reconstruction is based on a beat-by-beat basis.
  7. 7. A method for measuring electrical potentials in a heart cavity, the method comprising:
    inserting a percutaneous probe into the heart cavity, the probe including a terminal end portion having a plurality of electrodes, the terminal end having a spiral shape, and,
    positioning the probe for non-contact with the endocardial surface of the heart,
    measuring the electrical potentials in the heart cavity with the probe.
  8. 8. A method according to claim 8, further comprising conforming the terminal end portion into the spiral shape after inserting.
  9. 9. A method according to claim 8, further comprising conforming the terminal end portion into the spiral shape before inserting
  10. 10. A method according to claim 8, where the terminal end portion includes a cross-section that is generally cylindrical.
  11. 11. A method according to claim 8, where the spiral shape includes at least one of: a pigtail shape and a helix.
  12. 12. A method according to claim 8, further comprising, based on the measured electrical potentials and geometry data associated with the probe and the heart, reconstructing endocardial potentials on the endocardial surface of the heart.
  13. 13. A system for determining electrical potentials on an endocardial surface of a heart, the system comprising:
    a spiral-shaped catheter probe adapted to be positioned for non-contact with the endocardial surface during measurement in a cavity of the heart, the terminal end portion having a plurality of electrodes to measure electrical potentials in the cavity,
    an imaging means for capturing geometric data on the probe and the endocardial surface;
    processor instructions for determining a geometric relationship between the probe surface and the endocardial surface based on the geometric data, and,
    processor instructions for determining endocardial potentials based on the measured electrical potentials and the geometric relationship.
  14. 14. A system according to claim 13, where the imaging means includes at least one of: a CT scan, an MRI, an ultrasound, and an X-ray.
  15. 15. A system according to claim 13, further including processor instructions for generating at least one of: electrograms and isochrones.
  16. 16. A method to determine electrical potentials throughout an endocardial surface of a heart, the method comprising:
    inserting a spiral-shaped catheter probe into a cavity of the heart, the probe positioned in a cavity of the heart for non-contact with the endocardial surface during measurement, the probe having a terminal end portion having a plurality of electrodes to measure electrical potentials,
    measuring electrical potentials at the plurality of electrodes during a single heart-beat,
    determining a geometric relationship between the probe surface and the endocardial surface, and,
    determining the endocardial potentials based on the measured electrical potentials during the single heart-beat and the geometric relationship.
  17. 17. A method according to claim 16, where determining a geometric relationship includes providing an image of the endocardial surface and the probe based on at least one of: a CT scan, an MRI, an X-ray, and an ultrasound.
  18. 18. A method according to claim 16, where inserting includes inserting at least one of: a pigtail-shaped probe and a helix-shaped probe.
US10807941 1997-07-31 2004-03-24 Electrophysiological cardiac mapping system based on a non-contact non-expandable miniature multi-electrode catheter and method therefor Abandoned US20040181160A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US5434297 true 1997-07-31 1997-07-31
US09463427 US6839588B1 (en) 1997-07-31 1998-07-29 Electrophysiological cardiac mapping system based on a non-contact non-expandable miniature multi-electrode catheter and method therefor
US10807941 US20040181160A1 (en) 1997-07-31 2004-03-24 Electrophysiological cardiac mapping system based on a non-contact non-expandable miniature multi-electrode catheter and method therefor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10807941 US20040181160A1 (en) 1997-07-31 2004-03-24 Electrophysiological cardiac mapping system based on a non-contact non-expandable miniature multi-electrode catheter and method therefor

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
US09463427 Continuation US6839588B1 (en) 1997-07-31 1998-07-29 Electrophysiological cardiac mapping system based on a non-contact non-expandable miniature multi-electrode catheter and method therefor
PCT/US1998/015712 Continuation WO1999006112A1 (en) 1997-07-31 1998-07-29 Electrolphysiological cardiac mapping system based on a non-contact non-expandable miniature multi-electrode catheter and method therefor

Publications (1)

Publication Number Publication Date
US20040181160A1 true true US20040181160A1 (en) 2004-09-16

Family

ID=32965125

Family Applications (2)

Application Number Title Priority Date Filing Date
US09463427 Expired - Lifetime US6839588B1 (en) 1997-07-31 1998-07-29 Electrophysiological cardiac mapping system based on a non-contact non-expandable miniature multi-electrode catheter and method therefor
US10807941 Abandoned US20040181160A1 (en) 1997-07-31 2004-03-24 Electrophysiological cardiac mapping system based on a non-contact non-expandable miniature multi-electrode catheter and method therefor

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09463427 Expired - Lifetime US6839588B1 (en) 1997-07-31 1998-07-29 Electrophysiological cardiac mapping system based on a non-contact non-expandable miniature multi-electrode catheter and method therefor

Country Status (1)

Country Link
US (2) US6839588B1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040082870A1 (en) * 1997-07-31 2004-04-29 Yoram Rudy Systems and methods for determining a surface geometry
US8369930B2 (en) 2009-06-16 2013-02-05 MRI Interventions, Inc. MRI-guided devices and MRI-guided interventional systems that can track and generate dynamic visualizations of the devices in near real time
US9259290B2 (en) 2009-06-08 2016-02-16 MRI Interventions, Inc. MRI-guided surgical systems with proximity alerts

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6839588B1 (en) * 1997-07-31 2005-01-04 Case Western Reserve University Electrophysiological cardiac mapping system based on a non-contact non-expandable miniature multi-electrode catheter and method therefor
US7187964B2 (en) * 2001-09-27 2007-03-06 Dirar S. Khoury Cardiac catheter imaging system
US7337006B2 (en) 2004-09-08 2008-02-26 Spinal Modulation, Inc. Methods and systems for modulating neural tissue
US9205261B2 (en) 2004-09-08 2015-12-08 The Board Of Trustees Of The Leland Stanford Junior University Neurostimulation methods and systems
US20120277839A1 (en) 2004-09-08 2012-11-01 Kramer Jeffery M Selective stimulation to modulate the sympathetic nervous system
EP1809174A4 (en) * 2004-10-05 2008-04-23 Cuoretech Pty Ltd Heart analysis method and apparatus
US8038625B2 (en) * 2005-09-15 2011-10-18 St. Jude Medical, Atrial Fibrillation Division, Inc. System and method for three-dimensional mapping of electrophysiology information
US8229545B2 (en) 2005-09-15 2012-07-24 St. Jude Medical, Atrial Fibrillation Division, Inc. System and method for mapping complex fractionated electrogram information
US7988639B2 (en) * 2006-05-17 2011-08-02 St. Jude Medical, Atrial Fibrillation Division, Inc. System and method for complex geometry modeling of anatomy using multiple surface models
US7729752B2 (en) 2006-06-13 2010-06-01 Rhythmia Medical, Inc. Non-contact cardiac mapping, including resolution map
US7515954B2 (en) 2006-06-13 2009-04-07 Rhythmia Medical, Inc. Non-contact cardiac mapping, including moving catheter and multi-beat integration
US7505810B2 (en) * 2006-06-13 2009-03-17 Rhythmia Medical, Inc. Non-contact cardiac mapping, including preprocessing
EP2051625A2 (en) * 2006-08-03 2009-04-29 Christoph Scharf Method and device for determining and presenting surface charge and dipole densities on cardiac walls
FR2906123A1 (en) * 2006-09-25 2008-03-28 Ela Medical Soc Par Actions Si Method for reconstruction of a surface electrocardiogram from an endocardial electrogram
US8068920B2 (en) 2006-10-03 2011-11-29 Vincent A Gaudiani Transcoronary sinus pacing system, LV summit pacing, early mitral closure pacing, and methods therefor
US9314618B2 (en) * 2006-12-06 2016-04-19 Spinal Modulation, Inc. Implantable flexible circuit leads and methods of use
US9427570B2 (en) * 2006-12-06 2016-08-30 St. Jude Medical Luxembourg Holdings SMI S.A.R.L. (“SJM LUX SMI”) Expandable stimulation leads and methods of use
CA2671575A1 (en) * 2006-12-06 2008-06-12 Spinal Modulation, Inc. Grouped leads for spinal stimulation
EP2091594B1 (en) * 2006-12-06 2018-06-06 Spinal Modulation Inc. Delivery devices for stimulating nerve tissue on multiple spinal levels
CA2671250A1 (en) 2006-12-06 2008-06-12 Spinal Modulation, Inc. Hard tissue anchors and delivery devices
US9044592B2 (en) * 2007-01-29 2015-06-02 Spinal Modulation, Inc. Sutureless lead retention features
US20080190438A1 (en) * 2007-02-08 2008-08-14 Doron Harlev Impedance registration and catheter tracking
US20080221423A1 (en) * 2007-03-05 2008-09-11 Khoury Dirar S Cardiac Catheter Imaging System
WO2009025824A1 (en) 2007-08-20 2009-02-26 Medtronic, Inc. Implantable medical lead with biased electrode
US8326418B2 (en) * 2007-08-20 2012-12-04 Medtronic, Inc. Evaluating therapeutic stimulation electrode configurations based on physiological responses
US8103327B2 (en) 2007-12-28 2012-01-24 Rhythmia Medical, Inc. Cardiac mapping catheter
US8538509B2 (en) 2008-04-02 2013-09-17 Rhythmia Medical, Inc. Intracardiac tracking system
EP2317915A4 (en) 2008-08-11 2013-01-16 Univ St Louis Systems and methods for on-site and real-time electrocardiographic imaging (ecgi)
US8167876B2 (en) 2008-10-27 2012-05-01 Rhythmia Medical, Inc. Tracking system using field mapping
CN102202729B (en) * 2008-10-27 2014-11-05 脊髓调制公司 Selective stimulation systems and signal parameters for medical conditions
CN102387834B (en) * 2009-01-14 2016-02-24 脊髓调制公司 Stimulation lead, delivery system and methods of use
CA2758459A1 (en) * 2009-03-24 2010-10-30 Spinal Modulation, Inc. Pain management with stimulation subthreshold to paresthesia
US9398862B2 (en) * 2009-04-23 2016-07-26 Rhythmia Medical, Inc. Multi-electrode mapping system
US8103338B2 (en) * 2009-05-08 2012-01-24 Rhythmia Medical, Inc. Impedance based anatomy generation
US8571647B2 (en) 2009-05-08 2013-10-29 Rhythmia Medical, Inc. Impedance based anatomy generation
JP5711221B2 (en) * 2009-05-15 2015-04-30 スパイナル・モデュレーション・インコーポレイテッドSpinal Modulation Inc. How to neuromodulation spinal tissue, system, and device
US8728065B2 (en) * 2009-07-02 2014-05-20 St. Jude Medical, Atrial Fibrillation Division, Inc. Apparatus and methods for contactless electrophysiology studies
US20110213260A1 (en) * 2010-02-26 2011-09-01 Pacesetter, Inc. Crt lead placement based on optimal branch selection and optimal site selection
US9131869B2 (en) 2010-05-11 2015-09-15 Rhythmia Medical, Inc. Tracking using field mapping
US9002442B2 (en) 2011-01-13 2015-04-07 Rhythmia Medical, Inc. Beat alignment and selection for cardiac mapping
US8428700B2 (en) 2011-01-13 2013-04-23 Rhythmia Medical, Inc. Electroanatomical mapping
CN103561811A (en) 2011-02-02 2014-02-05 脊髓调制公司 Devices, systems and methods for the targeted treatment of movement disorders
CA2831116C (en) * 2011-04-22 2015-04-14 Topera, Inc. Basket style cardiac mapping catheter having spline bends for detection of cardiac rhythm disorders
EP2994039A1 (en) 2013-05-06 2016-03-16 Boston Scientific Scimed Inc. Persistent display of nearest beat characteristics during real-time or play-back electrophysiology data visualization
WO2014185977A1 (en) 2013-05-14 2014-11-20 Boston Scientific Scimed Inc. Representation and identification of activity patterns during electro-physiology mapping using vector fields
US9220435B2 (en) * 2013-10-09 2015-12-29 St. Jude Medical, Cardiology Division, Inc. System and method for generating electrophysiology maps
CN105592778A (en) 2013-10-14 2016-05-18 波士顿科学医学有限公司 High resolution cardiac mapping electrode array catheter
US9717429B2 (en) 2013-10-31 2017-08-01 St. Jude Medical, Cardiology Division, Inc. System and method for analyzing biological signals and generating electrophyisology maps
WO2015187386A1 (en) 2014-06-03 2015-12-10 Boston Scientific Scimed, Inc. Electrode assembly having an atraumatic distal tip
CN106413539A (en) 2014-06-04 2017-02-15 波士顿科学医学有限公司 Electrode assembly

Citations (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4203451A (en) * 1978-03-17 1980-05-20 Panico Joseph J Cardiovascular analysis, method and apparatus
US4535783A (en) * 1982-08-05 1985-08-20 Kontron Holding A.G. Personal electrocardiology recorder
US4649924A (en) * 1984-08-14 1987-03-17 Consiglio Nazionale Delle Ricerche Method for the detection of intracardiac electrical potential fields
US4805631A (en) * 1985-04-09 1989-02-21 Roi Du Maroc Ii Sa Majeste H Device for the detection, the study and the supervision of diseases, and in particular heart diseases, resulting in electrically recordable manifestations
US4991580A (en) * 1989-03-30 1991-02-12 Invivo Research, Inc. Method of improving the quality of an electrocardiogram obtained from a patient undergoing magnetic resonance imaging
US4991587A (en) * 1985-08-09 1991-02-12 Picker International, Inc. Adaptive filtering of physiological signals in physiologically gated magnetic resonance imaging
US5020540A (en) * 1987-10-09 1991-06-04 Biometrak Corporation Cardiac biopotential analysis system and method
US5042499A (en) * 1988-09-30 1991-08-27 Frank Thomas H Noninvasive electrocardiographic method of real time signal processing for obtaining and displaying instantaneous fetal heart rate and fetal heart rate beat-to-beat variability
US5086776A (en) * 1990-03-06 1992-02-11 Precision Diagnostics, Inc. Apparatus and method for sensing cardiac performance
US5161539A (en) * 1991-05-09 1992-11-10 Physio-Control Method and apparatus for performing mapping-type analysis including use of limited electrode sets
US5239999A (en) * 1992-03-27 1993-08-31 Cardiac Pathways Corporation Helical endocardial catheter probe
US5297549A (en) * 1992-09-23 1994-03-29 Endocardial Therapeutics, Inc. Endocardial mapping system
US5311866A (en) * 1992-09-23 1994-05-17 Endocardial Therapeutics, Inc. Heart mapping catheter
US5311873A (en) * 1992-08-28 1994-05-17 Ecole Polytechnique Comparative analysis of body surface potential distribution during cardiac pacing
US5433198A (en) * 1993-03-11 1995-07-18 Desai; Jawahar M. Apparatus and method for cardiac ablation
US5483968A (en) * 1991-06-25 1996-01-16 Technion Research And Development Foundation Ltd. Method and apparatus for analyzing the electrical activity of the heart
US5487391A (en) * 1994-01-28 1996-01-30 Ep Technologies, Inc. Systems and methods for deriving and displaying the propagation velocities of electrical events in the heart
US5503149A (en) * 1990-07-09 1996-04-02 Beavin; William C. Computer simulation of live organ using arthroscopic and/or laparoscopic data
US5553611A (en) * 1994-01-06 1996-09-10 Endocardial Solutions, Inc. Endocardial measurement method
US5568809A (en) * 1993-07-20 1996-10-29 Biosense, Inc. Apparatus and method for intrabody mapping
US5680860A (en) * 1994-07-07 1997-10-28 Cardiac Pathways Corporation Mapping and/or ablation catheter with coilable distal extremity and method for using same
US5938694A (en) * 1993-11-10 1999-08-17 Medtronic Cardiorhythm Electrode array catheter
US5997526A (en) * 1996-03-25 1999-12-07 The Uab Research Foundation Shape memory catheter
US6240307B1 (en) * 1993-09-23 2001-05-29 Endocardial Solutions, Inc. Endocardial mapping system
US6839588B1 (en) * 1997-07-31 2005-01-04 Case Western Reserve University Electrophysiological cardiac mapping system based on a non-contact non-expandable miniature multi-electrode catheter and method therefor

Patent Citations (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4203451A (en) * 1978-03-17 1980-05-20 Panico Joseph J Cardiovascular analysis, method and apparatus
US4535783A (en) * 1982-08-05 1985-08-20 Kontron Holding A.G. Personal electrocardiology recorder
US4649924A (en) * 1984-08-14 1987-03-17 Consiglio Nazionale Delle Ricerche Method for the detection of intracardiac electrical potential fields
US4805631A (en) * 1985-04-09 1989-02-21 Roi Du Maroc Ii Sa Majeste H Device for the detection, the study and the supervision of diseases, and in particular heart diseases, resulting in electrically recordable manifestations
US4991587A (en) * 1985-08-09 1991-02-12 Picker International, Inc. Adaptive filtering of physiological signals in physiologically gated magnetic resonance imaging
US5020540A (en) * 1987-10-09 1991-06-04 Biometrak Corporation Cardiac biopotential analysis system and method
US5042499A (en) * 1988-09-30 1991-08-27 Frank Thomas H Noninvasive electrocardiographic method of real time signal processing for obtaining and displaying instantaneous fetal heart rate and fetal heart rate beat-to-beat variability
US4991580A (en) * 1989-03-30 1991-02-12 Invivo Research, Inc. Method of improving the quality of an electrocardiogram obtained from a patient undergoing magnetic resonance imaging
US5086776A (en) * 1990-03-06 1992-02-11 Precision Diagnostics, Inc. Apparatus and method for sensing cardiac performance
US5503149A (en) * 1990-07-09 1996-04-02 Beavin; William C. Computer simulation of live organ using arthroscopic and/or laparoscopic data
US5161539A (en) * 1991-05-09 1992-11-10 Physio-Control Method and apparatus for performing mapping-type analysis including use of limited electrode sets
US5483968A (en) * 1991-06-25 1996-01-16 Technion Research And Development Foundation Ltd. Method and apparatus for analyzing the electrical activity of the heart
US5239999A (en) * 1992-03-27 1993-08-31 Cardiac Pathways Corporation Helical endocardial catheter probe
US5311873A (en) * 1992-08-28 1994-05-17 Ecole Polytechnique Comparative analysis of body surface potential distribution during cardiac pacing
US5297549A (en) * 1992-09-23 1994-03-29 Endocardial Therapeutics, Inc. Endocardial mapping system
US5311866A (en) * 1992-09-23 1994-05-17 Endocardial Therapeutics, Inc. Heart mapping catheter
US5433198A (en) * 1993-03-11 1995-07-18 Desai; Jawahar M. Apparatus and method for cardiac ablation
US5568809A (en) * 1993-07-20 1996-10-29 Biosense, Inc. Apparatus and method for intrabody mapping
US6240307B1 (en) * 1993-09-23 2001-05-29 Endocardial Solutions, Inc. Endocardial mapping system
US5938694A (en) * 1993-11-10 1999-08-17 Medtronic Cardiorhythm Electrode array catheter
US5553611A (en) * 1994-01-06 1996-09-10 Endocardial Solutions, Inc. Endocardial measurement method
US5487391A (en) * 1994-01-28 1996-01-30 Ep Technologies, Inc. Systems and methods for deriving and displaying the propagation velocities of electrical events in the heart
US5680860A (en) * 1994-07-07 1997-10-28 Cardiac Pathways Corporation Mapping and/or ablation catheter with coilable distal extremity and method for using same
US5997526A (en) * 1996-03-25 1999-12-07 The Uab Research Foundation Shape memory catheter
US6839588B1 (en) * 1997-07-31 2005-01-04 Case Western Reserve University Electrophysiological cardiac mapping system based on a non-contact non-expandable miniature multi-electrode catheter and method therefor

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040082870A1 (en) * 1997-07-31 2004-04-29 Yoram Rudy Systems and methods for determining a surface geometry
US20050197587A1 (en) * 1997-07-31 2005-09-08 Case Western Reserve University Determining a surface geometry of an object
US6975900B2 (en) 1997-07-31 2005-12-13 Case Western Reserve University Systems and methods for determining a surface geometry
US7471973B2 (en) 1997-07-31 2008-12-30 Case Western Reserve University Determining a surface geometry of an object
US9439735B2 (en) 2009-06-08 2016-09-13 MRI Interventions, Inc. MRI-guided interventional systems that can track and generate dynamic visualizations of flexible intrabody devices in near real time
US9259290B2 (en) 2009-06-08 2016-02-16 MRI Interventions, Inc. MRI-guided surgical systems with proximity alerts
US8396532B2 (en) 2009-06-16 2013-03-12 MRI Interventions, Inc. MRI-guided devices and MRI-guided interventional systems that can track and generate dynamic visualizations of the devices in near real time
US8768433B2 (en) 2009-06-16 2014-07-01 MRI Interventions, Inc. MRI-guided devices and MRI-guided interventional systems that can track and generate dynamic visualizations of the devices in near real time
US8825133B2 (en) 2009-06-16 2014-09-02 MRI Interventions, Inc. MRI-guided catheters
US8886288B2 (en) 2009-06-16 2014-11-11 MRI Interventions, Inc. MRI-guided devices and MRI-guided interventional systems that can track and generate dynamic visualizations of the devices in near real time
US8369930B2 (en) 2009-06-16 2013-02-05 MRI Interventions, Inc. MRI-guided devices and MRI-guided interventional systems that can track and generate dynamic visualizations of the devices in near real time

Also Published As

Publication number Publication date Type
US6839588B1 (en) 2005-01-04 grant

Similar Documents

Publication Publication Date Title
US5687737A (en) Computerized three-dimensional cardiac mapping with interactive visual displays
US6226542B1 (en) Three-dimensional reconstruction of intrabody organs
US6711429B1 (en) System and method for determining the location of a catheter during an intra-body medical procedure
US7774051B2 (en) System and method for mapping electrophysiology information onto complex geometry
US6725085B2 (en) Method and apparatus for characterizing cardiac tissue from local electrograms
US6856830B2 (en) Method and apparatus of three dimension electrocardiographic imaging
US6400981B1 (en) Rapid mapping of electrical activity in the heart
US20050203375A1 (en) System and method for passively reconstructing anatomical structure
US20040006268A1 (en) System and method of recording and displaying in context of an image a location of at least one point-of-interest in a body during an intra-body medical procedure
US20070232949A1 (en) Method For Simultaneous Bi-Atrial Mapping Of Atrial Fibrillation
US8494608B2 (en) Method and apparatus for mapping a structure
US20090099468A1 (en) Automated Processing of Electrophysiological Data
US8340751B2 (en) Method and apparatus for determining tracking a virtual point defined relative to a tracked member
US8326419B2 (en) Therapy optimization via multi-dimensional mapping
US20120184863A1 (en) Electroanatomical mapping
US20070270703A1 (en) Methods and apparatus of three dimensional cardiac electrophysiological imaging
US6826421B1 (en) Endocardial mapping catheter
USRE41334E1 (en) Endocardial mapping system
US20090262109A1 (en) Illustrating a three-dimensional nature of a data set on a two-dimensional display
US6957101B2 (en) Transient event mapping in the heart
US20090264752A1 (en) Method And Apparatus For Mapping A Structure
US6892091B1 (en) Catheter, method and apparatus for generating an electrical map of a chamber of the heart
US20070197929A1 (en) Mapping of complex fractionated atrial electrogram
US6368285B1 (en) Method and apparatus for mapping a chamber of a heart
US20060116575A1 (en) Method and system for registering an image with a navigation reference catheter

Legal Events

Date Code Title Description
AS Assignment

Owner name: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF

Free format text: CONFIRMATORY LICENSE;ASSIGNOR:CASE WESTERN RESERVE UNIVERSITY;REEL/FRAME:043541/0764

Effective date: 20170907

AS Assignment

Owner name: NATIONAL INSTITUTES OF HEALTH, MARYLAND

Free format text: CONFIRMATORY LICENSE;ASSIGNOR:CASE WESTERN RESERVE UNIVERSITY;REEL/FRAME:045323/0208

Effective date: 20180323